Tetravalent influenza vaccine(MDCK cell)(Aimei Hissen Vaccine)

四价流感病毒裂解疫苗（MDCK细胞）（艾美诚信生物）

Report date: 2024/12/05 16:32:06

Base Information

Drug NameTetravalent influenza vaccine(MDCK cell)(Aimei Hissen Vaccine)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLanzhou Bailing Biotechnology Co LtdAimei Hissen Vaccine(Dalian) Co LtdAim Vaccine Co Ltd +[4] 
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAimei Hissen Vaccine(Dalian) Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A